![]() |
市场调查报告书
商品编码
1734811
2032 年塑胶管瓶市场预测:按材料类型、封盖类型、产能、应用、最终用户、地区进行的全球分析Plastic Vials Market Forecasts to 2032 - Global Analysis By Material Type, Closure Type, Capacity, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球塑胶管瓶市场预计在 2025 年达到 49 亿美元,到 2032 年将达到 79 亿美元,预测期内的复合年增长率为 7.1%。
塑胶管瓶是小型圆柱形容器,通常由聚乙烯、聚丙烯或 PET 等聚合物製成。设计用于安全储存、运输和分配液体、粉末和少量固体样品。塑胶管瓶通常用于製药、实验室、化妆品和诊断应用,它重量轻、抗碎,是管瓶的经济实惠的替代品。它们通常配有螺旋盖、卡扣盖或滴管盖,以确保产品安全、防止污染并提供易用性。
根据环境管理评估研究所(IEMA)的数据,自 1950 年代以来,全球已生产了约 83 亿吨塑胶。
製药和生物製药行业的成长
对疫苗、注射药物和诊断解决方案的需求不断增长,加速了对可靠包装的需求,塑胶管瓶具有耐化学性、轻鬆操作和成本效益等优点。此外,慢性病的增加和全球人口老化正在推动药品消费量的增加,迫使製造商采用先进的塑胶管瓶解决方案来确保产品的安全性和完整性。医疗保健基础设施的持续成长继续推动市场向前发展。
原物料价格波动
原物料价格波动,尤其是聚丙烯和聚乙烯等聚合物的价格波动,是塑胶管瓶市场的主要限制因素。这些波动受到油价波动、供应链中断和不断变化的环境法规等因素的影响。此外,对永续包装和回收政策的日益重视可能会影响原材料的可用性和成本结构。投入成本的不可预测性对製造商维持稳定的价格和盈利构成了挑战,从而限制了市场扩张。
新兴市场医疗支出不断成长
随着亚太、拉丁美洲和非洲国家投资扩大医疗保健基础设施和改善治疗机会,包括塑胶管瓶的药品包装需求正在激增。此外,政府加大疫苗接种计划力度以及本地製药製造业的普及也进一步加速了这一趋势。不断增长的中产阶级人口和不断提高的医疗保健意识正在推动持续的需求,使市场参与者能够利用这些新兴机会。
管瓶更换
管瓶因其优异的阻隔性、化学惰性和既定的监管可接受性而传统上受到青睐,特别是对于敏感的生技药品和高价值药品。此外,对塑胶浸出物和环境永续性的担忧可能会推动人们转向玻璃替代品。此外,轻质、防碎玻璃技术的进步可能会削弱塑胶管瓶的竞争优势,迫使製造商进行创新并使其产品与众不同。
新冠疫情对塑胶管瓶市场产生了重大影响,疫苗生产和分发激增,推动了前所未有的需求。对疫苗和诊断剂的安全、无菌包装的迫切需求加速了塑胶管瓶的采用,尤其是在大规模疫苗宣传活动中。此外,医疗保健领域的供应链中断和一次性塑胶的使用增加也促进了市场的成长。然而,疫情也加剧了人们对塑胶废弃物管理的担忧,促使业界重新关注永续包装解决方案。
预计预测期内聚丙烯(PP)部分将占最大份额。
预计预测期内聚丙烯 (PP) 部分将占据最大的市场占有率。聚丙烯的优点在于其优异的耐化学性、耐用性和成本效益,使其成为药品包装的首选材料。此外,PP管瓶重量轻、抗碎,并可与多种药物相容,包括酸性和碱性製剂。随着环保意识的增强,其可回收性使其更具吸引力。 PP 在确保产品安全性和完整性方面的多功能性和可靠性使其成为製造商和最终用户的首选材料,并帮助其保持市场领先地位。
预计在预测期内,螺旋盖部分将以最高的复合年增长率成长。
预计螺旋盖部分将在预测期内实现最高的成长率。螺旋盖因其安全封闭、易于使用和防篡改特性而受到重视,这些对于维持药品的无菌性和安全性至关重要。此外,与自动化和大规模生产流程的兼容性有助于製造商更有效率地业务。製药和消费品领域对易于使用、可重新密封和抗污染封盖的需求不断增长,推动了螺旋盖的快速普及,为该领域的强劲增长奠定了基础。
预计亚太地区将在预测期内占据最大的市场占有率。这一优势源于该地区庞大的人口、快速的都市化以及不断扩张的製药和医疗保健产业。中国和印度等国家是主要贡献者,受益于强大的製造能力、高效的生产和不断增加的医疗保健投资。此外,包装药品需求的成长和当地製药商的激增加强了亚太地区的领导地位,使其成为塑胶管瓶生产和消费的重要中心。
预计亚太地区在预测期内的复合年增长率最高。这一显着增长将受到医疗保健支出激增、先进封装采用率提高以及政府促进本地製造业倡议的推动。此外,该地区蓬勃发展的经济发展、不断增长的中阶人口以及对医疗保健的日益重视正在推动持续的需求。永续包装的创新和电子商务的快速扩张将进一步推动市场成长。
According to Stratistics MRC, the Global Plastic Vials Market is accounted for $4.9 billion in 2025 and is expected to reach $7.9 billion by 2032 growing at a CAGR of 7.1% during the forecast period. Plastic vials are small, cylindrical containers typically made from polymers like polyethylene, polypropylene, or PET. They are designed to securely store, transport, and dispense liquids, powders, or small solid samples. Commonly used in pharmaceuticals, laboratories, cosmetics, and diagnostics, plastic vials offer lightweight, shatter-resistant, and cost-effective alternatives to glass vials. They often feature screw caps, snap-on lids, or dropper tops to ensure product safety, prevent contamination, and provide ease of use.
According to data from the Institute of Environmental Management Assessment (IEMA), since the 1950s, approximately 8.3 billion metric tons of plastic have been produced globally.
Growing pharmaceutical and biopharmaceutical industry
Increasing demand for vaccines, injectable medications, and diagnostic solutions has accelerated the need for reliable packaging, with plastic vials offering advantages such as chemical resistance, lightweight handling, and cost-effectiveness. Furthermore, the rise in chronic diseases and the aging global population have led to higher consumption of pharmaceuticals, compelling manufacturers to adopt advanced plastic vial solutions to ensure product safety and integrity. This ongoing growth in healthcare infrastructure continues to propel the market forward.
Price fluctuations of raw materials
Price volatility in raw materials, particularly polymers like polypropylene and polyethylene, poses a significant restraint for the plastic vials market. These fluctuations are influenced by changes in crude oil prices, supply chain disruptions, and evolving environmental regulations. Additionally, the increasing emphasis on sustainable packaging and recycling policies can impact raw material availability and cost structures. Such unpredictability in input costs challenges manufacturers' ability to maintain stable pricing and profitability, potentially limiting market expansion.
Rising healthcare expenditure in emerging markets
Countries in Asia Pacific, Latin America, and Africa invest in expanding healthcare infrastructure and improving access to medical treatments, and the demand for pharmaceutical packaging, including plastic vials, is surging. Moreover, government initiatives to enhance immunization programs and the proliferation of local pharmaceutical manufacturing further amplify this trend. The growing middle-class population and increasing awareness about healthcare drive sustained demand, enabling market players to capitalize on these emerging opportunities.
Substitution by glass vials
Glass vials are traditionally preferred for their superior barrier properties, chemical inertness, and established regulatory acceptance, especially for sensitive biologics and high-value drugs. Additionally, concerns over plastic leachables and environmental sustainability may encourage a shift back to glass alternatives. Furthermore, advancements in lightweight and shatter-resistant glass technologies could erode the competitive advantages of plastic vials, compelling manufacturers to innovate and differentiate their product offerings.
The Covid-19 pandemic had a profound impact on the plastic vials market, driving unprecedented demand due to the surge in vaccine production and distribution. The urgent need for safe, sterile packaging for vaccines and diagnostic reagents accelerated the adoption of plastic vials, especially in mass immunization campaigns. Additionally, supply chain disruptions and increased use of single-use plastics in healthcare heightened market growth. However, the pandemic also intensified concerns over plastic waste management, prompting renewed focus on sustainable packaging solutions within the industry.
The polypropylene (PP) segment is expected to be the largest during the forecast period
The polypropylene (PP) segment is expected to account for the largest market share during the forecast period. Polypropylene's dominance stems from its excellent chemical resistance, durability, and cost-effectiveness, making it a preferred material for pharmaceutical packaging. Moreover, PP vials are lightweight, shatterproof, and compatible with a wide range of drugs, including acidic and alkaline formulations. Its recyclability further enhances its appeal amid growing environmental concerns. The versatility and reliability of PP in ensuring product safety and integrity make it the material of choice for manufacturers and end-users alike, sustaining its market leadership.
The screw caps segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the screw caps segment is predicted to witness the highest growth rate. Screw caps are favored for their secure sealing, ease of use, and tamper-evident features, which are crucial for maintaining the sterility and safety of pharmaceutical products. Additionally, their compatibility with automation and mass production processes enhances operational efficiency for manufacturers. The increasing demand for user-friendly, resealable, and contamination-resistant closures in both pharmaceutical and consumer applications is driving the rapid adoption of screw caps, positioning this segment for robust expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share. This dominance is attributed to the region's vast population, rapid urbanization, and expanding pharmaceutical and healthcare sectors. Countries such as China and India are major contributors, benefiting from robust manufacturing capabilities, cost-effective production, and rising healthcare investments. Furthermore, the growing demand for packaged medicines and the proliferation of local pharmaceutical manufacturers reinforce Asia Pacific's leadership, making it a pivotal hub for both production and consumption of plastic vials.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This remarkable growth is driven by surging healthcare expenditure, increasing adoption of advanced pharmaceutical packaging, and government initiatives promoting local manufacturing. Moreover, the region's dynamic economic development, burgeoning middle-class population, and heightened focus on healthcare accessibility fuel sustained demand. Innovations in sustainable packaging and the rapid expansion of e-commerce further accelerate market growth.
Key players in the market
Some of the key players in Plastic Vials Market include Amcor, Berry Global, Gerresheimer, AptarGroup, ALPLA Group, Stevanato Group, Schott, SGD Pharma, DWK Life Sciences, Origin Pharma Packaging, West Pharmaceutical Services, Bormioli Pharma, Pacific Vial Manufacturing, O.Berk Company, Comar, Alpha Packaging, Silgan Holdings and Corning.
In February 2025, Berry Global is introducing a high-quality post-consumer recycled (PCR) plastic polymer for non-contact-sensitive packaging, specifically aimed at the homecare and industrial sectors. Utilising many of the same processes used to produce Berry's proprietary contact-sensitive PCR, CleanStream(R) Home and Industrial is suitable for a wide variety of applications with exacting technical specifications. The purity degree of the recycled polymer enables it to be included in greater percentages in all types of packs and in areas which demand a high degree of functional performance, for example trigger spray heads and the lid, ring and handle of paint containers.
In December 2024, Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions.
In October 2023, Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry launches with COP (Cyclic Olefin Polymer) vials a particularly satisfactory solution for the filling and storage of highly sensitive biologics. They are suitable for mRNA active ingredients at -80°C and cryogenic temperatures. Gerresheimer is expanding its RTF portfolio of glass vials in various qualities with a product made of high-quality polymer which combines the best material properties of glass and plastic.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.